Pat Reilly had good reason to worry about Alzheimer’s disease: Her mother had it and she saw firsthand the havoc it could wreak on a family, much of it financial.
So Reilly, 77, a retired social worker in Ann Arbor, Michigan, applied for a long-term care insurance policy. Wary of enrolling people at risk for dementia, the insurance company tested her memory three times before issuing the policy.
However, Reilly knew something the insurer did not: She has inherited the ApoE4 gene, which increases the lifetime risk of developing Alzheimer’s.
“I decided I’d best get long-term care insurance,” she said.
About 5.5 million people in the US have Alzheimer’s disease and they constitute half of all nursing home residents. Yet very few people in the country have been tested for the ApoE4 gene.
However, last month, with the approval of the US Food and Drug Administration, the gene testing company 23andMe began offering tests that reveal whether people have the variant, as well as assessing their risks for developing such conditions as Parkinson’s and celiac disease.
Other genetics companies are planning to offer similar tests and soon millions of people will have a better idea of what their medical futures might be. Research has found that many, like Reilly, are likely to begin preparing for the worst.
However, for companies selling long-term care insurance, the tests could be a disaster, sending risky patients in search of policies even as those with fewer risks shy away, damaging an already fragile business.
“There is a question about whether the industry is in a death spiral anyway,” Consumer Federation of America director of insurance Robert Hunter said. “This could make it worse.”
The tests are simple: All people have to do is send away a saliva sample and pay US$199. Their disease risks, if they say they want to know them, will be delivered with a report on ancestry and on how their genes influence such traits as flushing when they drink alcohol or having straight hair.
The company does not reveal how many people have received disease-risk data, but it says that in Britain and Canada, where it has offered such testing for several years, about three-quarters of their customers have asked for it.
23andMe has sold its genetic services to more than 2 million people worldwide since 2007.
The issue for now is with long-term care insurance, not employment and not — at least so far — health insurance.
Under the Genetic Information Nondiscrimination Privacy Act, companies cannot ask employees to take gene tests and cannot use any such results in employment decisions; insurers are not permitted to require gene tests or to use the results in coverage decisions.
However, legislation proposed in the US House of Representatives would exempt corporate “wellness” programs from some of these requirements and the American Health Care Act, passed by the House, would permit US states to waive some insurance safeguards regarding pre-existing conditions.
Companies selling long-term care insurance — unlike medical insurers — are permitted to ask about health status and take future health into consideration when deciding whom to insure and how much to charge.
The 23andMe test results do not appear in people’s medical records and the company promises not to disclose identifiable findings to third parties.
It is up to the customers to reveal them — and the fear for insurers is that many will not.
Two-thirds of nursing home residents are on Medicaid, and the remaining private insurers are already struggling.
In the early 2000s, more than 100 firms offered long-term care insurance, according to the US Department of the Treasury. By the end of 2015, only 12 firms offered it and new enrollees fell from 171,000 to 104,000.
The insurers charged too little for the policies, experts say; policyholders have turned out to be much sicker than anticipated.
To pay for an unanticipated increase in policyholders who develop Alzheimer’s, insurers would have to raise prices, said Don Taylor, a professor of public policy at Duke University who has studied the issue.
Increasing numbers of people at low risk might decide the insurance was not worth the rising price. Even many at high risk would eventually find the policies unaffordable. It is the definition of an insurance death spiral.
If that happens, even more people with Alzheimer’s will end up on Medicaid, with the federal government paying for their nursing home care, said Mark Rothstein, director of the bioethics institute at the University of Louisville’s medical school.
Someone must pay, he said.
For 23andMe, the new tests are simply a way to help people learn about their genetic makeup.
“People clearly want information about themselves,” 23andMe chief executive Anne Wojcicki said. “There is a demand.”
Yet even if just a minority of 23andMe customers decided to game the insurance system, “it’s enough to perturb the market,” said Robert Cook-Deegan, a professor at the School for the Future of Innovation in Society at Arizona State University, who has studied the issue.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last